@neuralink is hosting an event in SF. october 16, afternoon. open to students at local universities and to interns working in-person in the bay area. invites are limited, apply below. app3.greenhouse.io/e/arnmvw

Last night I spoke with Brad Smith @ALScyborg, the first person with ALS to have @neuralink implanted. He has his voice back through AI and can even make dad jokes again. Absolutely incredible technology changing lives and bettering humanity. Thank you @elonmusk!

Congrats to the @Neuralink team for helping many people who have lost use of their body with our Telepathy implant that enables computer use simply by thinking! The next generation Neuralink cybernetic augment with 3X capability will be ready later this year. Pending regulatory approval, we are also ready to do our first Blindsight augment that will enable those who have even complete loss of vision to see in low resolution at first, leading to high resolution over time.

NEURALINK 2025: - Received FDA Breakthrough Device Designation for its speech restoration technology targeting severe speech impairments. - Launched its first clinical trial in the Middle East (UAE-PRIME) at Cleveland Clinic Abu Dhabi in partnership with the Department of Health Abu Dhabi. - Raised $650 million in Series E funding, led by investors including ARK Invest, Sequoia Capital, and Founders Fund, valuing the company at approximately $9 billion. - Launched clinical trials in the United Kingdom in partnership with University College London Hospitals and Newcastle Hospitals. - Performed its first procedures outside the United States, implanting devices in two patients with cervical spinal cord injuries at Toronto's University Health Network in Canada. - Completed two surgeries in Canada, marking the first non-US procedures. - The first UK participant, Paul, received an implant and controlled a computer with thoughts hours after surgery at University College London Hospitals. - Convoy project testing with participants controlling robotic arms with their BCIs. - Introduced an upgraded next-generation surgical robot with improved electrode thread insertion time of 1.5 seconds per thread, greater insertion depths over 50mm, enhances compatibility with 99% of anatomical variations globally, and lowers manufacturing costs for needle cartridges by 95%. - Announced goals for faster LASIK-like implant procedures in minutes and emphasized flexible electrode threads for safer neuron placement. - As of now it is estimated that Neuralink as 20 participants. Know are Noland Arbaugh (@ModdedQuad), Alex Conley (@Bcidesign), Bradford Smith (@ALScyborg), Michael Melgarejo, RJ Tanner, Rob Greiner (@greiner_ro52817), Jake Schneider (@PairedWith_P7), Nick Wray (@Telepath_8), Audrey Crews (@NeuraNova9), Paul, and Jon L. Noble (@CheckCanopy).

I do often wonder what's next